Trials / Unknown
UnknownNCT03937401
Oxytocin in MRI-HIFU
Use of Oxytocin in MRI-HIFU Treatment
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Turku University Hospital · Other Government
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Capability of oxytocin in improving the efficacy of MRI-HIFU is studied. Patients undergoing MRI-HIFU treatment are given oxytocin during treatment and the efficacy of the treatment will be analysed by patient reported symptom questionnaires and imaging data.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxytocin | Oxytocin infusion during MRI-HIFU treatment |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2019-12-30
- Completion
- 2021-01-01
- First posted
- 2019-05-03
- Last updated
- 2019-05-03
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT03937401. Inclusion in this directory is not an endorsement.